Latest Credit Facilities News

Alkane Resources has locked in a $110 million revolving credit facility alongside a $40 million contingent instrument facility, enhancing liquidity and banking ties to support its mining operations and growth projects.

Ramelius Resources has withdrawn forward-looking financial statements based on a high gold price assumption, issuing a revised investor presentation that reaffirms its strong production growth and shareholder return plans through to FY30.

Strike Resources has agreed to sell a further 28.52% indirect stake in its Apurimac Iron Ore Project to JE United Ltd for A$5.5 million, while securing a US$5 million credit facility to accelerate project development and iron ore marketing.

Westgold Resources has locked in a $600 million unsecured revolving credit facility with top-tier lenders, enhancing its financial flexibility and liquidity to support future growth.

Canyon Resources has mobilised its surface miner to the Minim Martap site, targeting first bauxite production in early Q2 2026 and shipment by Q3, fully funded despite a failed equity raise.

OM Holdings reported a modest decline in FY2025 revenue and EBITDA amid subdued market conditions but maintains a positive cash position and sets a stable production outlook for FY2026.

Capstone Copper has reported record-breaking copper production and adjusted EBITDA for Q4 and full-year 2025, while progressing key expansion projects and maintaining stable guidance for 2026.

Synlait Milk Limited has secured important amendments and waivers to its syndicated bank facilities, aligning its financial covenants with the upcoming sale of its North Island assets scheduled for April 2026.

SDI Limited reported a modest 2% dip in net profit for H1 FY26 despite a 2.7% rise in sales, driven by growth in aesthetics and exports. The company faces challenges from regulatory bans on Amalgam products while advancing plans for manufacturing upgrades and a potential acquisition.

Vinyl Group Ltd has reported a robust 49% increase in revenue for the first half of FY26, alongside a significant reduction in net loss, driven by strategic acquisitions and AI integration.

Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.

Australis Oil & Gas reported a $24.9 million loss in 2025, driven largely by impairment charges linked to strategic asset transactions. The company secured a major development partner and sold a significant stake in producing wells, enabling full debt repayment and bolstering cash reserves.